There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Benzodiazepines and the Diagnosis and Treatment of Anxiety Disorders
This on-demand activity can contribute to the 2 credits of continuing education every two years required of Alabama Controlled Substances Certificate holders.
Description This course will help providers understand the pharmacology of benzodiazepines and the clinical indications in the diagnosis and treatment of anxiety disorders.
Credits The Medical Foundation of Alabama designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Medical Association of the State of Alabama. The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.
Faculty Dr. Luke Engeriser is an assistant professor and residency training director for the University of South Alabama College of Medicine, department of psychiatry. Before entering medical school, he completed a master of arts in divinity at the University of Chicago and worked as a teacher of English in Torun, Poland. He attended medical school at Northwestern University in Chicago and completed his psychiatry residency training at Tripler Army Medical Center in Honolulu, HI. At Fort Benning, GA, he was chief of the department of behavioral health. After the Army, Dr. Engeriser was medical director of a mental health center in Rockland, Maine. He has served the past three years on the executive council of the Alabama Psychiatric Physicians Association. Dr. Engeriser is board certified in adult psychiatry, and his academic interests include treatment of combat veterans and spiritual/religious issues in psychiatry.
Teaching Method Didactic lecture with slides
CME Objectives After completing this activity, learners will be able to:
Describe the pharmacologic profiles of benzodiazepines, opiates and other controlled drugs specifically in the diagnosis and treatment of anxiety disorders.
Target Audience This activity is designed for Physicians, Physician Assistants and Advanced Nurse Practitioners who are certified to prescribe controlled substances.
Disclosure The speaker, planners and staff who control content have no relevant financial relationships to disclose. All relevant financial relationships have been mitigated.
Estimated Completion Time 45 minutes
Instructions for Earning Credit: Learner must review all of the content included in the online video course, pass the online post-test with a score of at least 70%, and complete the course evaluation electronically. Note: Post-test is automatically locked after four unsuccessful attempts.
Issue Date February 25, 2022
Expiration Date February 25, 2025
Course Fee: Free
Refund Policy: Registration is not refundable.
0.75 AMA PRA Category 1 Credit ™ The Medical Foundation of Alabama designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Medical Association of the State of Alabama. The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.
Customers Who Bought This Item Also Bought
(On Demand) Prescribing Controlled Drugs During a RxDA Epidemic, Part I and II
(On Demand) Case Studies from the Alabama Board of Medical Examiners (ALBME)
(On Demand) Controlled Substance Issues in Palliative Medicine and Geriatrics
(On Demand) Dilemmas in Controlled Substance Prescribing
(On Demand) Navigating the Prescription Drug Monitoring Program (PDMP)
(On Demand) Treating Postoperative Pain: A Better Way
(On Demand) Dr. Lorna Breen Heroes’ Foundation: A Path to Wellness for Healthcare Professionals
(On Demand) Post-Roe Abortion Law in Alabama
(On Demand) Medical Cannabis
(On Demand) Anaphylaxis without an Allergy: An Introduction to Mast Cell Disorders